Climb Bio, Inc.
CLYM
$16.33
$1.6010.86%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -57.62M | -52.79M | -59.85M | -50.75M | -46.76M |
| Total Depreciation and Amortization | 130.00K | 135.00K | 97.00K | 67.00K | 38.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 6.55M | 5.96M | 6.00M | 6.64M | 5.78M |
| Change in Net Operating Assets | -1.75M | -6.61M | -601.00K | -196.00K | 1.28M |
| Cash from Operations | -52.70M | -53.30M | -54.36M | -44.24M | -39.66M |
| Capital Expenditure | -369.00K | -186.00K | -186.00K | -186.00K | -77.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | 0.00 | 0.00 |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -29.05M | 32.82M | 3.02M | -75.93M | -163.09M |
| Cash from Investing | -29.42M | 32.63M | 2.83M | -76.11M | -163.16M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 103.77M | 70.00K | 65.00K | 291.00K | 2.56M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -86.00K | -86.00K | -86.00K | -250.00K | -250.00K |
| Cash from Financing | 103.69M | -16.00K | -21.00K | 41.00K | 2.31M |
| Foreign Exchange rate Adjustments | -- | 24.00K | 0.00 | -57.00K | 51.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 21.57M | -20.66M | -51.54M | -120.37M | -200.46M |